Fergus Kennedy

Fergus Kennedy has a diverse work experience in various roles and industries. From 2016 to 2017, they worked as a Global Health Intern at GSK and as an Independent Strategy Consultant at Owlstone Medical. In 2017, they also worked as a Business Development Intern at MedImmune and as an Independent Business Consultant at Cambridge Enterprise. From 2016 to 2021, Fergus worked at Eradigm Consulting, starting as an Analyst and progressing to Senior Associate Consultant, Consultant, and eventually Principal. At Eradigm, they led the Competitive Intelligence unit, working with teams across the pharma and biotech industry. In 2020, they joined Roche as a Cross-Portfolio Strategy Lead and later in 2023, they became the Director of Corporate Development at Resolution Therapeutics. Fergus has also demonstrated their innovative skills by winning the Healthcare Innovation category in the Telegraph STEM Awards 2016 for their project "ParaPatch," which aims to improve vaccination supply chains in developing countries using drones and microneedle vaccine patches. Overall, they have built a strong background in corporate development, strategy, and consultancy within the life sciences industry.

Fergus Kennedy completed their education at two prestigious universities. From 2013 to 2016, they attended the University of Oxford and earned a Bachelor's degree (First Class) in Biological Sciences. Following that, they pursued a Master's degree (Distinction) in MPhil Bioscience Enterprise at the University of Cambridge from 2016 to 2017.